These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37309470)

  • 41. Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives.
    Liu R; Staller K
    Drug Des Devel Ther; 2020; 14():1391-1400. PubMed ID: 32308371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.
    Love BL; Johnson A; Smith LS
    Am J Health Syst Pharm; 2014 Jul; 71(13):1081-91. PubMed ID: 24939497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
    Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
    J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea.
    Brenner DM; Sayuk GS
    Adv Ther; 2020 Jan; 37(1):83-96. PubMed ID: 31707713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plecanatide for the treatment of constipation-predominant irritable bowel syndrome.
    Miner PB
    Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):71-84. PubMed ID: 31985305
    [No Abstract]   [Full Text] [Related]  

  • 46. Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide.
    Yu SW; Rao SS
    Therap Adv Gastroenterol; 2014 Sep; 7(5):193-205. PubMed ID: 25177366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation.
    Corsetti M; Tack J
    United European Gastroenterol J; 2013 Feb; 1(1):7-20. PubMed ID: 24917937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review.
    Binienda A; Storr M; Fichna J; Salaga M
    Curr Drug Targets; 2018; 19(15):1774-1781. PubMed ID: 29284389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homeopathy for treatment of irritable bowel syndrome.
    Peckham EJ; Cooper K; Roberts ER; Agrawal A; Brabyn S; Tew G
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009710. PubMed ID: 31483486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article.
    Chen L; Ilham SJ; Feng B
    Anesth Pain Med; 2017 Apr; 7(2):e42747. PubMed ID: 28824858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women.
    Wagstaff AJ; Frampton JE; Croom KF
    Drugs; 2003; 63(11):1101-20. PubMed ID: 12749744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review.
    Okawa Y; Fukudo S; Sanada H
    Biopsychosoc Med; 2019; 13():10. PubMed ID: 31080496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options.
    Wechsler EV; Shah ED
    Drugs; 2021 Nov; 81(17):1953-1968. PubMed ID: 34727333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
    Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
    Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
    Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
    Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome.
    Niewinna K; Zielińska A; Fichna J
    Expert Opin Pharmacother; 2020 Jan; 21(1):73-84. PubMed ID: 31724881
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
    Mamieva Z; Poluektova E; Svistushkin V; Sobolev V; Shifrin O; Guarner F; Ivashkin V
    World J Gastroenterol; 2022 Mar; 28(12):1204-1219. PubMed ID: 35431513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.